ArticleOncotarget2019

Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society.

Yoshiaki Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.